282 related articles for article (PubMed ID: 31758544)
1. Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.
Shapiro L; Wong JC; Escayg A
Epilepsia; 2019 Dec; 60(12):2359-2369. PubMed ID: 31758544
[TBL] [Abstract][Full Text] [Related]
2. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice.
Shapiro L; Gado F; Manera C; Escayg A
Neuropharmacology; 2021 May; 188():108448. PubMed ID: 33450277
[TBL] [Abstract][Full Text] [Related]
4. Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors.
Powers MS; Breit KR; Chester JA
Alcohol Clin Exp Res; 2015 Dec; 39(12):2438-46. PubMed ID: 26756798
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB2 receptors and hypersensitivity to methamphetamine: Vulnerability to schizophrenia.
Canseco-Alba A; Tabata K; Momoki Y; Tabassum T; Horiuchi Y; Arinami T; Onaivi ES; Ishiguro H
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110924. PubMed ID: 38135096
[TBL] [Abstract][Full Text] [Related]
6. Scn1a dysfunction alters behavior but not the effect of stress on seizure response.
Sawyer NT; Helvig AW; Makinson CD; Decker MJ; Neigh GN; Escayg A
Genes Brain Behav; 2016 Mar; 15(3):335-47. PubMed ID: 26694226
[TBL] [Abstract][Full Text] [Related]
7. Effects of an epilepsy-causing mutation in the SCN1A sodium channel gene on cocaine-induced seizure susceptibility in mice.
Purcell RH; Papale LA; Makinson CD; Sawyer NT; Schroeder JP; Escayg A; Weinshenker D
Psychopharmacology (Berl); 2013 Jul; 228(2):263-70. PubMed ID: 23494229
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.
Amenta PS; Jallo JI; Tuma RF; Hooper DC; Elliott MB
J Neuroinflammation; 2014 Nov; 11():191. PubMed ID: 25416141
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor 1/2 double-knockout mice develop epilepsy.
Rowley S; Sun X; Lima IV; Tavenier A; de Oliveira ACP; Dey SK; Danzer SC
Epilepsia; 2017 Dec; 58(12):e162-e166. PubMed ID: 29105060
[TBL] [Abstract][Full Text] [Related]
11. An Scn1a epilepsy mutation in Scn8a alters seizure susceptibility and behavior.
Makinson CD; Dutt K; Lin F; Papale LA; Shankar A; Barela AJ; Liu R; Goldin AL; Escayg A
Exp Neurol; 2016 Jan; 275 Pt 1(0 1):46-58. PubMed ID: 26410685
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection.
Zarruk JG; Fernández-López D; García-Yébenes I; García-Gutiérrez MS; Vivancos J; Nombela F; Torres M; Burguete MC; Manzanares J; Lizasoain I; Moro MA
Stroke; 2012 Jan; 43(1):211-9. PubMed ID: 22020035
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
[TBL] [Abstract][Full Text] [Related]
14. Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.
Ramirez SH; Haskó J; Skuba A; Fan S; Dykstra H; McCormick R; Reichenbach N; Krizbai I; Mahadevan A; Zhang M; Tuma R; Son YJ; Persidsky Y
J Neurosci; 2012 Mar; 32(12):4004-16. PubMed ID: 22442067
[TBL] [Abstract][Full Text] [Related]
15. The CB
Ji X; Zeng Y; Wu J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445666
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.
Agudo J; Martin M; Roca C; Molas M; Bura AS; Zimmer A; Bosch F; Maldonado R
Diabetologia; 2010 Dec; 53(12):2629-40. PubMed ID: 20835701
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders.
Ishiguro H; Horiuchi Y; Tabata K; Liu QR; Arinami T; Onaivi ES
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042304
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca
Xia KK; Shen JX; Huang ZB; Song HM; Gao M; Chen DJ; Zhang SJ; Wu J
Acta Pharmacol Sin; 2019 Mar; 40(3):410-417. PubMed ID: 30202013
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids affect the mouse visual acuity via the cannabinoid receptor type 2.
Cécyre B; Bachand I; Papineau F; Brochu C; Casanova C; Bouchard JF
Sci Rep; 2020 Sep; 10(1):15819. PubMed ID: 32978469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]